![Charles Winter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Winter
Hoofd Techniek/Wetenschap/O&O bij
JANUX THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-05-2026
Profiel
Charles Winter is currently Chief Technical Officer at Janux Therapeutics, Inc. since 2021.
Former positions include Vice President-Chemistry, Manufacturing & Controls at AnaptysBio, Inc. (2020–2021), Vice President-Manufacturing & Controls at Synthorx, Inc. (2020), Head-Biologics at Denali Therapeutics, Inc. (2016–2018), Vice President-Manufacturing & Technology at Eden Biologics, Inc. (2015–2016), Director-Biologics Development at Gilead Sciences, Inc. (2011–2015), and Senior Group Leader & Principal Engineer at Genentech, Inc. (1994–2011).
Education includes undergraduate studies at the University of Wisconsin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-01-2026 | 106.321 ( 0,18% ) | 2 M $ | 31-05-2026 |
Actieve functies van Charles Winter
| Bedrijven | Functie | Begin |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
Eerdere bekende functies van Charles Winter
| Bedrijven | Functie | Einde |
|---|---|---|
| ANAPTYSBIO, INC. | Corporate Officer/Principal | 01-03-2021 |
| SYNTHORX, INC. | Corporate Officer/Principal | 01-08-2020 |
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 01-06-2018 |
| JHL BIOTECH, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2016 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-06-2015 |
Opleiding van Charles Winter
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
94
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that uses synthetic biology to discover and develop protein therapeutics | Health Technology |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
